Search Results - "ANDERSEN, HENRIK U."

The impact of upper extremity impairments on work and everyday life of people with type 1 diabetes—A nationwide controlled study by Wagner, Sabina, Nørgaard, Kirsten, Willaing, Ingrid, Olesen, Kasper, Andersen, Henrik U.

“…Aims The study objective was to explore how upper extremity impairments (UEIs) affect the everyday life and work‐life of people with type 1 diabetes (T1D) and…”
Get full text

RNA modifications by oxidation: A novel disease mechanism? by Poulsen, Henrik E., Specht, Elisabeth, Broedbaek, Kasper, Henriksen, Trine, Ellervik, Christina, Mandrup-Poulsen, Thomas, Tonnesen, Morten, Nielsen, Peter E., Andersen, Henrik U., Weimann, Allan

“…The past decade has provided exciting insights into a novel class of central (small) RNA molecules intimately involved in gene regulation. Only a small…”
Get full text

The novel inflammatory biomarker GlycA and triglyceride-rich lipoproteins are associated with the presence of subclinical myocardial dysfunction in subjects with type 1 diabetes mellitus by Puig-Jové, Carlos, Julve, Josep, Castelblanco, Esmeralda, Julián, M Teresa, Amigó, Núria, Andersen, Henrik U, Ahluwalia, Tarunveer S, Rossing, Peter, Mauricio, Dídac, Jensen, Magnus T, Alonso, Núria

“…Subjects with Type 1 diabetes mellitus (T1DM) have an increased incidence of heart failure (HF). Several pathophysiological mechanisms have been involved in…”
Get full text

MR-proANP and incident cardiovascular disease in patients with type 2 diabetes with and without heart failure with preserved ejection fraction by Jensen, Jesper, Schou, Morten, Kistorp, Caroline, Faber, Jens, Hansen, Tine W, Jensen, Magnus T, Andersen, Henrik U, Rossing, Peter, Vilsbøll, Tina, Jørgensen, Peter G

“…Mid-regional pro-atrial natriuretic peptide (MR-proANP) is a useful biomarker in outpatients with type 2 diabetes (T2D) to diagnose heart failure (HF)…”
Get full text

Upper-Extremity Impairments in Type 1 Diabetes: Results From a Controlled Nationwide Study by Wagner, Sabina, Nørgaard, Kirsten, Willaing, Ingrid, Olesen, Kasper, Andersen, Henrik U

“…This study aimed to identify current and lifetime prevalence of upper-extremity impairments (UEIs) among individuals with type 1 diabetes and explore factors…”
Get full text

The Effect of Real-Time Continuous Glucose Monitoring in Pregnant Women With Diabetes: A randomized controlled trial by SECHER, Anna L, RINGHOLM, Lene, ANDERSEN, Henrik U, DAMM, Peter, MATHIESEN, Elisabeth R

“…To assess whether intermittent real-time continuous glucose monitoring (CGM) improves glycemic control and pregnancy outcome in unselected women with…”
Get full text

Twelve-Week Treatment With Liraglutide as Add-on to Insulin in Normal-Weight Patients With Poorly Controlled Type 1 Diabetes: A Randomized, Placebo-Controlled, Double-Blind Parallel Study by Frandsen, Christian S, Dejgaard, Thomas F, Holst, Jens J, Andersen, Henrik U, Thorsteinsson, Birger, Madsbad, Sten

“…This study investigated the efficacy and safety of once-daily liraglutide 1.2 mg versus placebo as add-on to insulin treatment in normal-weight patients with…”
Get full text

Liraglutide reduces hyperglycaemia and body weight in overweight, dysregulated insulin‐pump‐treated patients with type 1 diabetes: The Lira Pump trial—a randomized, double‐blinded, placebo‐controlled trial by Dejgaard, Thomas F., Schmidt, Signe, Frandsen, Christian S., Vistisen, Dorte, Madsbad, Sten, Andersen, Henrik U., Nørgaard, Kirsten

“…Aim To investigate the efficacy of adding the glucagon‐like peptide‐1 receptor agonist liraglutide to continuous subcutaneous insulin infusion (CSII) in…”
Get full text

Glucose Monitoring Metrics in Individuals With Type 1 Diabetes Using Different Treatment Modalities: A Real-World Observational Study by Nørgaard, Kirsten, Ranjan, Ajenthen G., Laugesen, Christian, Tidemand, Katrine G., Green, Allan, Selmer, Christian, Svensson, Jannet, Andersen, Henrik U., Vistisen, Dorte, Carstensen, Bendix

“…OBJECTIVE This study aimed to investigate the association between continuous glucose monitoring (CGM)-derived glycemic metrics and different insulin treatment…”
Get full text

Effects of continuous glucose monitor-recorded nocturnal hypoglycaemia on quality of life and mood during daily life in type 1 diabetes by Henriksen, Marie M., Andersen, Henrik U., Thorsteinsson, Birger, Pedersen-Bjergaard, Ulrik

“…Aims/hypothesis The aim of this work was to assess the effect of spontaneous nocturnal hypoglycaemia on quality of life and mood during subsequent days in type…”
Get full text

Does nocturnal hypoglycaemia really improve quality of life? Reply to Søholm U, Broadley MM, Choudhary P et al [letter] by Henriksen, Marie M., Andersen, Henrik U., Thorsteinsson, Birger, Pedersen-Bjergaard, Ulrik

Get full text

Metabolic effect of adrenaline infusion in people with type 1 diabetes and healthy individuals by She, Rui, Suvitaival, Tommi, Andersen, Henrik U., Hommel, Eva, Nørgaard, Kirsten, Wojtaszewski, Jørgen F. P., Legido-Quigley, Cristina, Pedersen-Bjergaard, Ulrik

“…Aims/hypothesis As a result of early loss of the glucagon response, adrenaline is the primary counter-regulatory hormone in type 1 diabetes. Diminished…”
Get full text

780-P: Associations between Insulin Pump Self-Management and HbA1c by RYTTER, KAREN, MADSEN, KRISTOFFER P., ANDERSEN, HENRIK U., HOMMEL, EVA, PEDERSEN-BJERGAARD, ULRIK, SCHMIDT, SIGNE, NØRGAARD, KIRSTEN

“…Background and Aims: It is well-known that diabetes self-management is important for glycemic outcome, also among insulin pump users. We aimed to explore which…”
Get full text

745-P: Short-Acting Exenatide Added Three Times Daily to Insulin Therapy Improves Insulin Sensitivity in Type 1 Diabetes by JOHANSEN, NICKLAS, DEJGAARD, THOMAS F., LUND, ASGER, VILSBØLL, TINA, ANDERSEN, HENRIK U., KNOP, FILIP K.

“…Average life expectancy in type 1 diabetes is reduced by more than a decade due to cardiovascular (CV) disease. Reduced insulin sensitivity as assessed by low…”
Get full text

734-P: The Effect of Adjunctive Therapy with Liraglutide on Insulin Sensitivity in Overweight Persons with Type 1 Diabetes by DEJGAARD, THOMAS F., FRANDSEN, CHRISTIAN S., JOHANSEN, NICKLAS, MADSBAD, STEN, KNOP, FILIP K., ANDERSEN, HENRIK U.

“…Type 1 diabetes is associated with an almost threefold higher mortality rate than the general population, primarily driven by excess mortality from…”
Get full text

129-LB: A Comparison of CGM Metrics in People with Type 1 Diabetes Treated with Different Insulin Modalities by NØRGAARD, KIRSTEN, RANJAN, AJENTHEN G., LAUGESEN, CHRISTIAN, TIDEMAND, KATRINE G., ANDERSEN, HENRIK U., SVENSSON, JANNET, SELMER, CHRISTIAN, GREEN, ALLAN, VISTISEN, DORTE, CARSTENSEN, BENDIX

“…Background: There is a lack of real-world data comparing CGM data across different insulin treatment modalities. This study examined the association between…”
Get full text

Effect of fenofibrate on residual beta cell function in adults and adolescents with newly diagnosed type 1 diabetes: a randomised clinical trial by Hostrup, Pernille E, Schmidt, Tobias, Hellsten, Simon B, Gerwig, Rebekka H, Størling, Joachim, Johannesen, Jesper, Sulek, Karolina, Hostrup, Morten, Andersen, Henrik U, Buschard, Karsten, Hamid, Yasmin, Pociot, Flemming

“…Fenofibrate, a peroxisome proliferator-activated receptor alpha agonist, shows some promise in alleviating beta cell stress and preserving beta cell function…”
Get full text

Breastfeeding at night is rarely followed by hypoglycaemia in women with type 1 diabetes using carbohydrate counting and flexible insulin therapy by Ringholm, Lene, Roskjær, Ann B., Engberg, Susanne, Andersen, Henrik U., Secher, Anna L., Damm, Peter, Mathiesen, Elisabeth R.

“…Aims/hypothesis Hypoglycaemia in association with breastfeeding is a feared condition in mothers with type 1 diabetes. Thus, routine carbohydrate intake at…”
Get full text

369-P: Effects of Nocturnal Hypoglycemia on Quality of Life and Mood During Daily Life in Type 1 Diabetes—A CGM-Based Analysis by HENRIKSEN, MARIE M., ANDERSEN, HENRIK U., THORSTEINSSON, BIRGER, PEDERSEN-BJERGAARD, ULRIK

“…Objective: To assess the effect of spontaneous nocturnal hypoglycemia on quality of life and mood the subsequent days in type 1 diabetes. Research Design and…”
Get full text

Liraglutide enhances insulin secretion and prolongs the remission period in adults with newly diagnosed type 1 diabetes (the NewLira study): A randomized, double‐blind, placebo‐controlled trial by Dejgaard, Thomas F., Frandsen, Christian S., Kielgast, Urd, Størling, Joachim, Overgaard, Anne J., Svane, Maria S., Olsen, Markus Harboe, Thorsteinsson, Birger, Andersen, Henrik U., Krarup, Thure, Holst, Jens J., Madsbad, Sten

“…Aim To test the effect of the glucagon‐like peptide‐1 receptor agonist, liraglutide, on residual beta‐cell function in adults with newly diagnosed type 1…”
Get full text